Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity At-the-Market Offering (Details)

v3.22.2.2
Stockholders' Equity At-the-Market Offering (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 28, 2021
Jul. 14, 2021
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]                    
Number of shares authorized to be sold under equity distribution agreement (in shares)     8,750,000           8,750,000  
Number of common shares issued under equity distribution agreement and outstanding as of period-end (in shares)     2,135,109           2,135,109  
Accumulated proceeds from issuance of common shares under equity distribution agreement     $ 134,000           $ 134,000  
Number of shares of stock issued during period (in shares) 7,500,000 10,000,000                
Issuance of stock, net of offering costs $ 193,700 $ 256,500 $ 5,357 $ 82 $ 323 $ 256,611 $ 93 $ 99    
At the Market Offering [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of shares of stock issued during period (in shares)     259,500     3,050     259,500 3,050
Issuance of stock, net of offering costs     $ 5,300     $ 100     $ 5,300 $ 100